DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. (DRTS) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.6% since its last earnings release on August 10, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Alpha Tau Medical Ltd.
Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors.
Sector
Healthcare
Industry
Medical Instruments/Supply